# Synthetic research brief: Cedar trial
The supplied excerpts agree on a 14-day trial [S1 ¶1; S2 ¶2]. The seat limit is unresolved: 5 versus 10 [S1 ¶1; S2 ¶2]. CSV export is documented and was observed on one account [S1 ¶1; S3 ¶3].

| Claim | Supporting evidence | Opposing evidence / scope | Assessment |
| --- | --- | --- | --- |
| Trial lasts 14 days | S1 ¶1; S2 ¶2 | No contradiction in the corpus | High agreement within this synthetic corpus |
| Trial allows 5 seats | S1 ¶1 | S2 ¶2 states 10 for all trials; no version specified | Unresolved |
| Trial allows 10 seats | S2 ¶2 | S1 ¶1 states 5; no version specified | Unresolved |
| CSV export works | S1 ¶1; S3 ¶3 | S3 tested one account only | Documented; one-account observation |
| CSV is the only export format | S1 ¶1 | S3 ¶3 did not test other formats; it cannot confirm exclusivity | Single-source assertion |

The dates alone do not resolve the seat conflict. Recommendation: obtain an authoritative version-specific trial limit before communicating one number. To verify export exclusivity, obtain a current complete format list or a scoped test covering other formats. These are proposed next steps, not completed research.

## Source inventory (all synthetic)
- S1: Trial guide, 2026-09-01, paragraph 1, supplied excerpt.
- S2: Help note, 2026-09-03, paragraph 2, supplied excerpt.
- S3: Internal test memo, 2026-09-04, paragraph 3, supplied excerpt.

Check: all five claim rows cite their excerpts. No seat average, real-product assertion, or invented URL is used.